Brown, Lisle/Cummings’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.7K | Hold |
270
| – | – | 0.02% | 302 |
|
|
2025
Q1 | $60.4K | Hold |
270
| – | – | 0.02% | 311 |
|
|
2024
Q4 | $61.7K | Hold |
270
| – | – | 0.02% | 307 |
|
|
2024
Q3 | $65.9K | Hold |
270
| – | – | 0.02% | 295 |
|
|
2024
Q2 | $51.7K | Hold |
270
| – | – | 0.02% | 307 |
|
|
2024
Q1 | $53.5K | Hold |
270
| – | – | 0.02% | 284 |
|
|
2023
Q4 | $46.4K | Hold |
270
| – | – | 0.02% | 294 |
|
|
2023
Q3 | $39.9K | Hold |
270
| – | – | 0.02% | 281 |
|
|
2023
Q2 | $59K | Hold |
270
| – | – | 0.03% | 263 |
|
|
2023
Q1 | $59.1K | Hold |
270
| – | – | 0.03% | 263 |
|
|
2022
Q4 | $56.2K | Hold |
270
| – | – | 0.03% | 253 |
|
|
2022
Q3 | $58.9K | Hold |
270
| – | – | 0.03% | 243 |
|
|
2022
Q2 | $56.6K | Hold |
270
| – | – | 0.03% | 246 |
|
|
2022
Q1 | $65.5K | Hold |
270
| – | – | 0.03% | 242 |
|
|
2021
Q4 | $70.3K | Buy |
+270
| New | +$70.3K | 0.04% | 237 |
|